Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:XENT

Intersect ENT (XENT) Stock Price, News & Analysis

Intersect ENT logo

About Intersect ENT Stock (NASDAQ:XENT)

Key Stats

Today's Range
$28.24
$28.24
50-Day Range
$28.24
$28.24
52-Week Range
$15.92
$28.25
Volume
14,512 shs
Average Volume
351,526 shs
Market Capitalization
$954.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.

Receive XENT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intersect ENT and its competitors with MarketBeat's FREE daily newsletter.

XENT Stock News Headlines

Kiatnakin Bank PCL (KKP)
XENT Historical Data
Crypto Crash Ahead? (27 Experts Weigh In)
Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!
See More Headlines

XENT Stock Analysis - Frequently Asked Questions

Intersect ENT, Inc. (NASDAQ:XENT) posted its quarterly earnings results on Tuesday, November, 2nd. The medical equipment provider reported ($0.48) EPS for the quarter, missing the consensus estimate of ($0.42) by $0.06. The medical equipment provider earned $24.40 million during the quarter, compared to analysts' expectations of $29.63 million. Intersect ENT had a negative net margin of 161.94% and a negative trailing twelve-month return on equity of 709.52%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Intersect ENT investors own include SEASPAN CORP/SH SH (SSW), Textainer Group (TGH), iShares MSCI Brazil ETF (EWZ), Costamare (CMRE), Mimecast (MIME), EOG Resources (EOG) and Air Transport Services Group (ATSG).

Company Calendar

Last Earnings
11/02/2021
Today
11/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:XENT
Employees
433
Year Founded
N/A

Profitability

Net Income
$-159,630,000.00
Net Margins
-161.94%
Pretax Margin
-163.16%

Debt

Sales & Book Value

Annual Sales
$106.75 million
Book Value
($2.06) per share

Miscellaneous

Free Float
33,104,000
Market Cap
$954.91 million
Optionable
Optionable
Beta
1.45

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:XENT) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners